Matthew Hay has worked as a Subject Matter Expert, cannabinoid scientist, technology developer, and formulator in the cannabinoid space for over six years. Mr. Hay brings a vast knowledge of the endocannabinoid system and its relation to, and effect on, human health to the company. Mr. Hay has focused his efforts on technology and methods to improve bioavailability and delivery of cannabinoids, believing that science is the next frontier in cannabinoid therapy. Mr. Hay has broad experience in the cannabinoid industry overall, having worked with cultivators, extractors, manufactures, testing facilities, marketing firms, banks, and logistic companies. Matthew is a passionate advocate of this industry and strives to bring the best products the customers that need them.